Navigation Links
Blocking Enzyme Can Treat Breast Cancer

Canadian scientists claim to have found a treatment, which could block the action of an enzyme that fuels the growth of breast cancer.

The enzyme PTP1B appears to fuel tumor growth and drugs that block this enzyme may be useful in treating the disease. About 40 percent of human breast cancers have been shown to have excessively high levels of this enzyme.

Michel Tremblay and colleagues at McGill University in Montreal found that deleting PTP1B in mice led to a significant delay in the onset of breast tumors. It also prevented the secondary development of tumors in the lungs, reported the online edition BBC News.

Over-expression of PTP1B has already been implicated in the development of diabetes and obesity, where it shuts down insulin receptors, leading a number of drug companies to develop compounds to block its action.

The animals were treated for just two weeks, but the beneficial effects were seen for two months.

Tremblay said: "This study is very exciting for cancer patients. However, it won't cure cancer alone. It's another tool to tackle cancers.


Page: 1

Related medicine news :

1. Blocking Pain Found To Slow Down The Healing Process
2. Improving The Survival Of Lung Cancer Patients By Blocking The Effects Of Estrogen
3. Protein Fragments Blocking Cures Alzheimers Disease
4. Multiple Sclerosis Can Be Treated By Blocking Fat Hormone
5. Ventilation Systems Not Effective in Blocking Tobacco Smoke
6. Study Says - Blocking aP2 Protein Prevents Airway Diseases
7. Sunscreen Blocking UVA Radiation Receives Federal Approval
8. New Cancer-Blocking Algae Found
9. Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities
10. Enzyme may be target for obesity drugs
11. Researchers trick Alzheimers Enzyme
Post Your Comments:

(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: